Abstract
Heavy-light chain pairs as an alternative method to monitor isatuximab-based treatment responses in multiple myeloma patients
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have